Objectives Previous studies have demonstrated gaps in achievement of low-density
lipoprotein-cholesterol (LDL-C) goals among patients at very high cardiovascular risk. We …

Introduction: Patients with established coronary artery disease (CAD) are at very high risk for
cardiovascular events. Methods: The DAUSSET study is a national, multicenter, non …

The reduction of low-density lipoprotein cholesterol with lipid lowering therapy has
demonstrated to decrease the risk of developing cardiovascular complications during the …

Background Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what
extent GPs' follow guidelines in routine clinical practice or whether additional clinical factors …

Background: Poland represents a country of high cardiovascular (CV) risk. The association
between lipid abnormalities and increased CV risk is well established. Therefore, it is …

Background: The implementation of treatment guidelines is lacking worldwide. Objectives:
To examine whether follow-up in a specialized lipid clinic improves the achievement rate of …

Background There may be a considerable gap between LDL cholesterol (LDL-C) and blood
pressure (BP) goal values recommended by the guidelines and results achieved in daily …

The role of hypercholesterolemia as a risk factor for cardiovascular disease has been well-
documented. Hypercholesterolemia is the most prevalent modifiable risk factor in Poland …

To help prevent the development of coronary heart disease (CHD), the European and NCEP
guidelines have recommended target cholesterol levels for all individuals. Lifestyle changes …

Background The entire risk factor profile should be taken into account when considering
initiating cholesterol lowering drug treatment. Recent treatment guidelines are therefore …